The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case-control study in Abidjan, Ivory Coast

Article Abstract:

African women who are HIV positive appear to have more severe cases of pelvic inflammatory disease (PID) than comparable women who are HIV negative. A group of 170 adult African women attending five gynecologic clinics in Abidjan, Ivory Coast had HIV testing, a physical examination, and laboratory testing and were diagnosed with PID. Of them, 57 were HIV positive. HIV-positive women were 2.5 times more likely to have a fever, 7.8 times more likely to have a genital ulcer, 2.6 times more likely to have a tubal or ovarian mass as visualized on an ultrasound scan, 6.5 times more likely to require surgery, and 3.5 times more likely to be hospitalized compared with HIV-negative women. However, both groups responded well to antibiotic therapy. Within four days, 95% of HIV-positive patients reported improvement of symptoms as did 93% of HIV-negative patients, and none continued to run a fever.

Physiological aspects, HIV infection, HIV infections, Pelvic inflammatory disease

---

Comparison of Once-Daily and Twice-Daily Dosing of 0.75% Metronidazole Gel in the Treatment of Bacterial Vaginosis

Article Abstract:

Once-daily use of metronidazole vaginal gel appears to be just as effective as twice-daily gel in the treatment of bacterial vaginosis. Researchers treated 514 women with the vaginal infection with either once-daily or twice-daily metronidazole for five days. About 60% of the women in both groups were cured of the infection.

---

Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: A randomized controlled trial

Article Abstract:

The metronidazole 0.75 percent gel is compared with ovules containing metronidazole 500 mg and nystatin 100,000 U, for intravaginal treatment of bacterial vaginosis (BV). Metronidazole/nystatin ovules were significantly more effective than metronidazole gel and unprotected sex predicted recurrence after initial improvement.

Nystatin, Bacterial vaginosis

Similar abstracts:

• Abstracts: Testing for in utero immunodeficiency virus infection with fetal blood sampling. Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus
• Abstracts: Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection. Culture-independent analysis of virginal microflora: The unrecognized association of Atopobium vaginae with bacterial vaginosis
• Abstracts: Bone density changes in women who receive thromboprophylaxis in pregnancy. Thromboprophylaxis and pregnancy: Two randomized controlled pilot trails that used low-molecular-weight heparin
• Abstracts: Transabdominal amnioinfusion in oligohydramnios at term before induction of labor with intact membranes: a randomized clinical trial
• Abstracts: Clinical and ultrasonographic features of dextroposition of the fetal heart. Use of the mitral valve-tricuspid valve distance as a marker of fetal endocardial cushion defects

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.